Showing results (481-490 of 36,425) with videos related to
Sort By:
Pageof 3,643
Frontiers in Oncology|December 30, 2022
Evaluating breast ultrasound S-detect image analysis for small focal breast lesionsBoyuan Xing, Xiangyi Chen, Yalin Wang, et al.Frontiers in Oncology|December 30, 2022
Economic evaluation of first-line sugemalimab plus chemotherapy for metastatic non-small cell lung cancer in ChinaHao Wang, Li Liao, Yuan Xu, et al.Frontiers in Oncology|December 30, 2022
Targeted therapy of RET fusion-positive non-small cell lung cancerZixiong Shen, Binxu Qiu, Lin Li, et al.Frontiers in Oncology|December 30, 2022
Biparametric MRI-based radiomics classifiers for the detection of prostate cancer in patients with PSA serum levels of 4∼10 ng/mLYangbai Lu, Binfei Li, Hongxing Huang, et al.Frontiers in Oncology|December 30, 2022
Left versus right approach for middle and lower esophageal squamous cell carcinoma: A propensity score-matched studyXining Zhang, Kang Qi, Weiming Huang, et al.Frontiers in Oncology|December 30, 2022
Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patientSha-Sha Wang, Fang Wang, Zhen Zeng, et al.Frontiers in Oncology|January 2, 2023
Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemiaOliver Schleicher, Annkathrin Horndasch, Manuela Krumbholz, et al.Frontiers in Oncology|January 2, 2023
Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysisHao Zhao, Chun-Hao Liu, Yue Cao, et al.Frontiers in Oncology|January 2, 2023
Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?Annika Dhawan, Phillip M Pifer, Vlad C Sandulache, et al.Frontiers in Oncology|January 2, 2023
Study protocol of an open-label prospective phase II umbrella study of precise neoadjuvant therapy for patients with stage II-IIIB resectable non-small cell lung cancer (PURPOSE)Yiyang Wang, Haoran Zhai, Jiaming Wang, et al.Pageof 3,643